15 hours agoFlu Scan for Apr 28, 2017
15 hours agoNews Scan for Apr 28, 2017
15 hours agoWHO vaccine advisors weigh in on polio, cholera, Ebola, diphtheria
6/22/2017 » 6/25/20172017 OSAP Annual Conference
Pfizer Inc said on Tuesday the U.S. Food and Drug Administration had expanded the use of its best-selling pneumonia vaccine, Prevnar, to adults aged 18 through 49.
The vaccine, which is already approved for use in adults aged 50 and above, and children aged 6 weeks to 17 years, prevents invasive diseases caused by 13 Streptococcus pneumoniae strains.
OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2017. Sponsorship does not imply endorsement by OSAP of a company's products or services.